← Back to headlines
Incyte Lymphoma Therapy Shows 25% Increase in Cancer-Free Survival
A new lymphoma therapy developed by Incyte has demonstrated a 25% increase in cancer-free survival rates during a late-stage clinical trial. This positive outcome suggests a significant advancement in treatment options for lymphoma patients.
30 May, 17:46 — 30 May, 17:46
Sources
Showing 1 of 1 sources
